+

WO2008133196A1 - Material for regenerative medicine - Google Patents

Material for regenerative medicine Download PDF

Info

Publication number
WO2008133196A1
WO2008133196A1 PCT/JP2008/057574 JP2008057574W WO2008133196A1 WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1 JP 2008057574 W JP2008057574 W JP 2008057574W WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1
Authority
WO
WIPO (PCT)
Prior art keywords
regenerative medicine
matrix
genetically modified
modified gelatin
disclosed
Prior art date
Application number
PCT/JP2008/057574
Other languages
French (fr)
Japanese (ja)
Inventor
Shouji Ooya
Takayuki Kobayashi
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of WO2008133196A1 publication Critical patent/WO2008133196A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed is a material for regenerative medicine, which enables to reduce the risk of causing an infection in a collagen-like peptide, and to precisely design parameters required for a matrix for regenerative medicine. Specifically disclosed is a material for regenerative medicine, which comprises a genetically modified gelatin. The genetically modified gelatin is contacted with a biological tissue as a matrix.
PCT/JP2008/057574 2007-04-19 2008-04-18 Material for regenerative medicine WO2008133196A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-110041 2007-04-19
JP2007110041 2007-04-19

Publications (1)

Publication Number Publication Date
WO2008133196A1 true WO2008133196A1 (en) 2008-11-06

Family

ID=39925650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057574 WO2008133196A1 (en) 2007-04-19 2008-04-18 Material for regenerative medicine

Country Status (1)

Country Link
WO (1) WO2008133196A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010128672A1 (en) * 2009-05-07 2010-11-11 富士フイルム株式会社 Neovascularization inducer comprising genetically recombined gelatin
WO2011027850A1 (en) * 2009-09-04 2011-03-10 富士フイルム株式会社 Bone regeneration agent including gelatin
JP2012219100A (en) * 2011-04-12 2012-11-12 Fujifilm Corp Composition containing cell and biocompatible polymer
CN102791301A (en) * 2010-03-02 2012-11-21 富士胶片株式会社 Cell-supporting body and bone regeneration material
JP2013074936A (en) * 2011-09-29 2013-04-25 Fujifilm Corp Scaffold for vascular endothelial cell migration
JP2014012114A (en) * 2011-08-31 2014-01-23 Fujifilm Corp Cell structure for cell transplantation and cell aggregate for cell transplantation
WO2014050908A1 (en) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
JP2016174538A (en) * 2015-03-18 2016-10-06 富士フイルム株式会社 Tubular structure, method for producing cell structure, and method for producing tubular structure
CN111704663A (en) * 2020-06-29 2020-09-25 江南大学 A kind of preparation method of collagen hydrogel
CN111793127A (en) * 2020-06-17 2020-10-20 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN112661856A (en) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 Purification method and application of ELP collagen

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (en) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド Recombinantly prepared functional synthetic protein polymers
JP2001502548A (en) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション Stable expression of triple helix protein
JP2003516730A (en) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド Recombinant gelatin
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (en) * 2006-03-17 2007-10-25 Fujifilm Corp Biodegradable matrix homogeneously encapsulating medicament

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (en) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド Recombinantly prepared functional synthetic protein polymers
JP2001502548A (en) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション Stable expression of triple helix protein
JP2003516730A (en) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド Recombinant gelatin
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (en) * 2006-03-17 2007-10-25 Fujifilm Corp Biodegradable matrix homogeneously encapsulating medicament

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010128672A1 (en) * 2009-05-07 2010-11-11 富士フイルム株式会社 Neovascularization inducer comprising genetically recombined gelatin
JP5752033B2 (en) * 2009-05-07 2015-07-22 富士フイルム株式会社 Angiogenesis inducer containing genetically modified gelatin
JP2015033635A (en) * 2009-09-04 2015-02-19 富士フイルム株式会社 Granulation tissue formation agent comprising genetically modified gelatin
WO2011027850A1 (en) * 2009-09-04 2011-03-10 富士フイルム株式会社 Bone regeneration agent including gelatin
CN102625717A (en) * 2009-09-04 2012-08-01 富士胶片株式会社 Bone regeneration agent including gelatin
US9968661B2 (en) 2009-09-04 2018-05-15 Fujifilm Corporation Bone regeneration agent including gelatin
JP5642685B2 (en) * 2009-09-04 2014-12-17 富士フイルム株式会社 Bone regenerant containing gelatin
US8987204B2 (en) 2009-09-04 2015-03-24 Fujifilm Coporation Bone regeneration agent comprising gelatin
CN102791301A (en) * 2010-03-02 2012-11-21 富士胶片株式会社 Cell-supporting body and bone regeneration material
US9101686B2 (en) 2010-03-02 2015-08-11 Fujifilm Corporation Cell support and bone regeneration material
JP2016188235A (en) * 2011-04-12 2016-11-04 富士フイルム株式会社 Composition comprising cell and biocompatible polymer
JP2012219100A (en) * 2011-04-12 2012-11-12 Fujifilm Corp Composition containing cell and biocompatible polymer
US10406183B2 (en) 2011-04-12 2019-09-10 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP2014012114A (en) * 2011-08-31 2014-01-23 Fujifilm Corp Cell structure for cell transplantation and cell aggregate for cell transplantation
EP2578246A3 (en) * 2011-09-29 2015-01-14 Fujifilm Corporation Scaffold for vascular endothelial cell migration
JP2013074936A (en) * 2011-09-29 2013-04-25 Fujifilm Corp Scaffold for vascular endothelial cell migration
WO2014050908A1 (en) 2012-09-26 2014-04-03 富士フイルム株式会社 Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
US9932557B2 (en) 2012-09-26 2018-04-03 Fujifilm Corporation Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
JP2016174538A (en) * 2015-03-18 2016-10-06 富士フイルム株式会社 Tubular structure, method for producing cell structure, and method for producing tubular structure
CN111793127A (en) * 2020-06-17 2020-10-20 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN111793127B (en) * 2020-06-17 2021-11-02 江南大学 A type III human collagen and its encoding gene, recombinant bacteria and application
CN111704663A (en) * 2020-06-29 2020-09-25 江南大学 A kind of preparation method of collagen hydrogel
CN112661856A (en) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 Purification method and application of ELP collagen

Similar Documents

Publication Publication Date Title
WO2008133196A1 (en) Material for regenerative medicine
EP2288715A4 (en) LINKS OF HUMAN SERUM ALBUMIN AND ITS CONJUGATES
WO2008006895A3 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators
UY32177A (en) TREATMENT OF DIABETES IN PATIENTS WITH INSUFFICIENT GLUCEMIC CONTROL TO WEIGHT THERAPY WITH DRUG, ORAL OR NOT, ANTIDIABÉTICO
DOP2007000102A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONA SUBSTITUTED AS WELL AS ITS USE
EP2346520A4 (en) Curcuminoids and its metabolites for the application in ocular diseases
BRPI0906549A2 (en) Medical bandages with valves and kits containing them.
WO2008127402A3 (en) Biopolymer sensor and method of manufacturing the same
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
WO2007137072A3 (en) Assays for diagnosing and evaluating treatment options for fabry disease
UA108598C2 (en) HIGH-EFFICIENT CONJUGATES AND HYDROPHILIC STAPLING AGENTS (LINERS)
SG196838A1 (en) Gpr120 receptor agonists and uses thereof
WO2006092797A3 (en) Device and method for transporting and handling tissue
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
WO2011044443A3 (en) Matricryptic ecm peptides for tissue reconstruction
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
WO2009114712A3 (en) Assays for diagnosing and evaluating treatment options for pompe disease
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2008110374A3 (en) Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
EP2257254B8 (en) Patch
IL203762A (en) Use of a composition comprising collagen for the cultivation of biological cells
WO2007106369A3 (en) Case-finding systems and methods
WO2011103599A9 (en) Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
WO2011006508A3 (en) Adhesive patch with enzyme

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载